Ajax-Loading

AbbVie Inc - Deferred Long Term Liabilities

AbbVie Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Deferred-Long-Term-Liabilities" stands at 2.12 Billion United States Dollars as of 06/30/2023.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -5.81 percent compared to the value the year prior.
The 1 year change in percent is -5.81.
The 3 year change in percent is -55.61.
The 5 year change in percent is 27.19.

The Serie's long term average value is 3.55 Billion United States Dollars. It's latest available value, on 06/30/2023, is 40.16 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2020, to it's latest available value, on 06/30/2023, is +121.48%.
The Serie's change in percent from it's maximum value, on 06/30/2016, to it's latest available value, on 06/30/2023, is -70.42%.

Deferred Long Term Liabilities for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Deferred Long Term Liabilities905,699,262,464.00
LogoJohnson & Johnson - Deferred Long Term Liabilities486,508,953,600.00
LogoRoche Holding AG - Deferred Long Term Liabilities317,433,206,677.55
LogoAstraZeneca PLC - Deferred Long Term Liabilities280,205,508,085.11
LogoNovartis AG - Deferred Long Term Liabilities255,096,620,580.91